MAP3K13 and head and neck squamous cell carcinoma: To verify that GNE-3511 inhibits LZK catalytic activity in cells, we induced expression of dox-inducible LZK in the 3q amplicon-positive HNSCC cell line CAL33 (Figure S1A).